Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Claire Moffat, MD, MPH
Department of Immunology and Infectious Diseases, Harvard School of Public Health, Botswana-Harvard School of Public Health Partnership for Research and Education
Principal Investigator - Roger Shapiro, MD, MPH
Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Botswana-Harvard School of Public Health Partnership for Research and Education
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Marina Hosp., Bhp Study Clinic, Gaborone Shapiro Crs
Gaborone, Botswana
- Athlone Hosp., Bhp Study Clinic, Lobatse Shapiro Crs
Lobatse, Botswana
- Deborah Reteif Hosp., Bhp Study Clinic, Mochudi Shapiro Crs
Mochudi, Botswana
- Scottish Livingstone Hosp., Bhp Study Clinic, Molepolole Shapiro Crs
Molepolole, Botswana
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2006
- Primary completion
- 31 Mar 2009
- Completion
- 30 Sept 2010
- Last update posted
- 2 Nov 2021
- Registered enrollment
- 730
- Registry id
- NCT00270296
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.